Anti-reflux Mucosal Ablation (ARMA)
- 1 May 2025
- book chapter
- Published by Springer Nature
- p. 73-81
Abstract
No abstract availableKeywords
This publication has 13 references indexed in Scilit:
- Introducing antireflux mucoplasty with valve: a novel endoscopic treatment for GERDVideoGIE, 2024
- Pilot study on anti‐reflux mucoplasty: Advancing endoscopic anti‐reflux therapy for gastroesophageal reflux diseaseDigestive Endoscopy, 2023
- Clinical outcomes of anti‐reflux mucosal ablation for gastroesophageal reflux disease: An international bi‐institutional studyJournal of Gastroenterology and Hepatology, 2023
- Antireflux mucosectomy (ARMS) and antireflux mucosal ablation (ARMA) for gastroesophageal reflux disease: a systematic review and meta-analysisEndoscopy International Open, 2021
- Endoscopic treatment of proton pump inhibitor‐refractory gastroesophageal reflux disease with anti‐reflux mucosectomy: Experience of 109 casesDigestive Endoscopy, 2020
- Prevalence of Gastroesophageal Reflux Disease and Proton Pump Inhibitor-Refractory SymptomsGastroenterology, 2020
- Anti-reflux mucosal ablation (ARMA) as a new treatment for gastroesophageal reflux refractory to proton pump inhibitors: a pilot studyEndoscopy International Open, 2020
- Long-term efficacy of transoral incisionless fundoplication with Esophyx (Tif 2.0) and factors affecting outcomes in GERD patients followed for up to 6 years: a prospective single-center studySurgical Endoscopy, 2014
- Association of Long-Term Proton Pump Inhibitor Therapy with Bone Fractures and Effects on Absorption of Calcium, Vitamin B12, Iron, and MagnesiumCurrent Gastroenterology Reports, 2010
- A prospective randomized trial of sham, single-dose Stretta, and double-dose Stretta for the treatment of gastroesophageal reflux diseaseSurgical Endoscopy, 2009